SARS-CoV-2-neutralizing antibodies (NAbs) protect against COVID-19. A concern regarding
SARS-CoV-2 antibodies is whether they mediate disease enhancement. Here, we isolated …

… Emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants have
raised concerns about resistance to neutralizing antibodies elicited by previous infection or …

… This study was designed to identify SARS-CoV-2 neutralizing antibodies from a … screening
of antibodies produced from patient-derived PBMCs to identify high-affinity SARS-CoV-2 spike …

… induction of SARS-CoV-2 NAbs … neutralizing antibody titre and SARS-CoV-2 reinfection.
Therefore, further investigation of the correlation between reinfection and neutralizing antibodies …

… The purpose of this current study was to analyze the dynamics of neutralizing antibody levels
at different time since onset from different severity COVID-19 inpatients and convalescent …

… the evasion of neutralizing antibodies. Virus neutralizing antibodies are a major determinant
of … from infection in humans and macaques experimentally challenged with virus 3,4 . …

… of therapeutic antibodies and vaccines against coronavirus disease … neutralizing antibodies
against COVID-19 are summarized. We also highlight the importance of a fruitful antibody …

… Antibodies produced by survivors of coronavirus disease … neutralizing antibodies,
which confer strong protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)…

… SARS-CoV immune antibody library, and isolated a single chain Fv (scFv) with high specificity
and affinity by selection using whole SARS-CoV … scFv with neutralizing activity recognizes …

… The kinetics of the antibodies in SARS-CoV-2 patients is not clear due to … antibody responses
against the SARS-CoV-2 5 . Validated serological assays required to study the antibody …